TherapeuticsMD, Inc. 10-Q


Exhibit
10.6


EMPLOYMENT
AGREEMENT


THIS
EMPLOYMENT AGREEMENT (this “Agreement”), by and between TherapeuticsMD, Inc., a Nevada corporation (the
“Company”), and James C. D’Arecca (“Executive”) is entered into and effective as of the
1st day of June 2020 (the “Effective Date”).


WHEREAS,
the Company and Executive now wish to provide for terms and conditions of Executive’s continued employment with the Company,
pursuant to the terms and conditions set forth in this Agreement.


NOW,
THEREFORE, in consideration of the premises and of the mutual covenants set forth in this Agreement, the parties hereto agree
as follows:


1.            Employment and Duties.


(a)         Employment
and Term. The Company hereby agrees to employ Executive, and Executive hereby agrees to serve the Company, in accordance with
the terms and conditions set forth herein, for a period of three (3) years, commencing as of the Effective Date (such three (3)
year period, as it may be extended pursuant to this Section 1(a), the “Term”), unless sooner terminated
pursuant to Section 3 hereof. Commencing on the third anniversary of the Effective Date, and each anniversary thereafter,
the Term shall automatically be extended for one (1) additional year, unless at least ninety (90) days prior to such anniversary,
the Company or Executive shall have given notice in accordance with Section 8 hereof that it or Executive does not
wish to extend the Term.


(b)         Duties of Executive. Executive
shall serve as the Chief Financial Officer of the Company, shall diligently perform all services as may be reasonably assigned
to Executive by the Company’s Board of Directors (the “Board”) or the Company’s Chief Executive
Officer (the “CEO”), of if delegated by the CEO the President of the Company or the Executive Vice President
of Operations (the “President or EVP, Operations”). Executive shall exercise such power and authority as may
from time to time be delegated to Executive by the Board, the CEO, and the President or EVP, Operations. Executive shall
report solely and directly to the CEO (or to the President or EVP, Operations if instructed to by the CEO). During Executive’s
employment, Executive shall devote substantially all of Executive’s full business time, energy, and ability exclusively
to the business and interests of the Company, shall generally be physically present at the Company’s offices in Boca Raton,
Florida during normal business hours each week (other than permitted periods of working remotely, paid time off (“PTO”)
and on appropriate business travel for the benefit of the Company and shall not, without the Company’s prior written consent,
be engaged in any other business activity pursued for gain, profit, or other pecuniary advantage if such activity interferes in
any material respect with Executive’s duties and responsibilities hereunder. In Executive’s capacity as the Chief
Financial Officer of the Company, Executive shall do and perform all services, acts, or things necessary or advisable to manage
and conduct the business of the Company, subject to the policies and procedures set by the Company, including
but not limited to performing the Company’s budgeting and forecasting, record keeping, internal and external reporting; performing
financial risk management; managing – in conjunction with the CEO – the Company’s internal relations functions;
managing the Company’s fundraising plans and capital structure; maintaining the Company’s SOX compliance program, managing the
Company’s cash flow, overseeing the Company’s finance systems; managing taxes, treasury, and other functions, and managing the
finance organization. Except as otherwise agreed in writing by the Company, it shall not be a violation of this Agreement
for Executive, and Executive shall be permitted, to (i) serve on any civic or charitable boards; (ii) deliver lectures, fulfill
speaking engagements, or teach at educational institutions and other institutions; (iii) subject to any applicable Company policies,
make personal investments in such form or manner as will neither require Executive’s services in the operation or affairs
of the companies or enterprises in which such investments are made nor subject Executive to any conflict of interest with respect
to Executive’s duties to the Company; and (iv) serve, with the written approval of the Board, as a director of one or more
private or public companies, in each case so long as any such activities do not significantly interfere with the performance of
Executive’s responsibilities under this Agreement, create a conflict of interest, or create an adverse interest or position
detrimental to Company.






     


     


    

 


(c)        Policies.
Executive shall faithfully adhere to, execute, and fulfill all lawful policies established by the Company as are communicated
to Executive by the Company.


(d)        Place
of Performance. In connection with Executive’s employment by the Company, Executive shall be based at the Company’s
principal executive offices in Boca Raton, Florida.


2.          
Compensation. For all services rendered by Executive, the Company shall compensate Executive as follows:


(a)        Base
Salary. Effective on the Effective Date, the base salary (“Base Salary”) payable to Executive shall be
Four hundred twenty thousand dollars ($420,000) per year, payable on a regular basis in accordance with the Company’s standard
payroll procedures, but not less than monthly. The Board or a committee of the Board shall review Executive’s performance
on at least an annual basis and may make increases to such Base Salary if, in its sole discretion, any such increase is warranted.
The Board may reduce the Base Salary without Executive’s consent only if such reduction applies in the same or greater percentage
to all other executives of the Company at the Chief level and above.


(b)        Annual
Short-Term Incentive. Executive shall be entitled to participate in the Company’s annual short-term incentive compensation
program, as such program may exist from time to time, at a level commensurate with that being offered to other executives of the
Company at the Chief level and above. For calendar years beginning on or after January 1, 2020, the percentage of Base Salary
targeted as annual cash short-term incentive compensation for each calendar year during the Term shall be seventy-five percent
(75%) of Base Salary (the “Targeted Annual Bonus Award”). Executive acknowledges that the amount of annual
short-term incentive compensation, if any, to be awarded shall be at the sole, good faith discretion of the Board or a committee
of the Board, may be less or more than the Targeted Annual Bonus Award, and will be based on a number of factors determined by
the Board or a committee of the Board for each calendar year, including the Company’s performance in connection with, among
other factors, the clinical program, regulatory filings, commercialization and/or sales, and Executive’s individual performance.
Any annual short-term incentive compensation earned for any calendar year shall be paid in the immediately following calendar
year, as soon as practicable. Except as set forth in Sections 3(b)(ii), 3(b)(iii), and 3(b)(iv) hereof.
Executive must be employed by the Company on the date on which short-term incentive compensation is paid in order to receive such
short-term incentive compensation. Executive’s 2020 bonus will not be prorated due to a mid-year start.



    2


     


    

(c)            Long-Term
Incentive.   Executive shall be entitled to participate in the Company’s
long-term incentive compensation program, as such program may exist from time to time, at a level commensurate with that being
offered to other executives of the Company at the Chief level and above. Executive acknowledges that the amount of long-term incentive
compensation, if any, to be awarded shall be at the sole, good faith discretion of the Board or a committee of the Board, and
will be based on a number of factors determined by the Board or a committee of the Board for the applicable performance period,
including the Company’s performance in connection with, among other factors, the clinical program, regulatory filings, commercialization
and/or sales, and Executive’s individual performance. Any long-term incentive compensation earned for the applicable performance
period shall be paid within the first two-and-a-half (21⁄2) months of the calendar year immediately following the calendar
year in which the applicable performance period ends. Except as otherwise set forth herein, Executive must be employed by the
Company on the date on which long-term incentive compensation is paid to receive such long-term incentive compensation.


(d)            Restricted Stock Units. As
soon as practicable following the Effective Date and subject to approval by the Board of Directors, the Company will grant to
Executive six hundred fifty-one thousand five hundred (651,500) restricted stock units (“RSUs”) pursuant to
the Company’s 2019 Stock Incentive Plan, as the same may be amended from time to time (the “Plan”), which
RSUs will vest in equal amounts annually over (3) years from the Effective Date, one-third vesting on each of June 1, 2021, June
1, 2022, and June 1, 2023, subject to Executive’ continued employment with the Company and the terms and conditions in the
Plan and an award agreement to be entered into between the Company and Executive. Executive will also be granted 151,500 performance
share units (“PSUs”) that will vest if the Company achieves EBITDA breakeven, provided EBITDA breakeven is accomplished
on or before December 31, 2022.


(e)            Executive
Perquisites, Benefits, and Other Compensation. Executive shall be entitled to receive additional benefits and compensation
from the Company in such form and to such extent as specified below:


(i)      
Insurance Coverage. During the Term, and as otherwise provided within the provisions of each of the respective plans, the
Company shall make available to Executive all employee benefits to which other executives of the Company are entitled to receive,
subject to the eligibility requirements and other provisions of such arrangements as applicable to executives of the Company generally.
Such benefits shall include, but shall not be limited to, comprehensive health and major medical insurance, dental and life insurance,
and short-term and long-term disability. The Company will provide to Executive D&O insurance and other insurance coverage
typically provided to in-house legal counsel, including legal liability coverage, as reasonably necessary.


(ii)      Reimbursement
for Expenses. Reimbursement for business travel and other out-of-pocket expenses reasonably incurred by Executive in the performance
of Executive’s services under this Agreement, which shall be paid as paid for other executives of the Company at the Chief
level and above., including, but not limited to, industry appropriate seminars and subscriptions and applicable licensing and
continuing education expenses. All reimbursable expenses shall be appropriately documented in reasonable detail by Executive upon
submission of any request for reimbursement and shall be in a format and manner consistent with the Company’s expense reporting
policy. Reimbursements under this section shall be paid within sixty (60) days following date of submission.



    3


     


    

(iii)     Paid
Time Off. Executive shall be eligible to accrue PTO and utilize and carryover from year to year such PTO, consistent with
the Company’s policies and procedures in effect from time to time for executives of the Company at the Chief level and above.


(iv)      Other
Executive Perquisites. The Company shall provide Executive with other executive perquisites as may be made available to or
deemed appropriate for Executive by the Board or a committee of the Board and participation in all other Company-wide employee
benefits as are available to the Company’s executives from time to time, including any plans, programs, or arrangements
relating to retirement, deferred compensation, profit sharing, 401(k), and employee stock ownership.


(v)       Working
Facilities. During the Term, the Company shall furnish Executive with an office, staffing and administrative support and such
other facilities and services suitable to Executive’s position with the Company and adequate for the performance of Executive’s
duties hereunder, which will be reviewed and provided based on the Company’s needs.


(vi)     Commute Expenses and Relocation. The
Company will reimburse Executive for his reasonable expenses with respect to his temporary housing or hotel, rental vehicle, and
airfare to commute from his home to Boca Raton, Florida for a reasonable, mutually agreed upon period of time not to exceed two
(2) years from the Effective Date. The Company will reimburse Executive for his reasonable expenses with respect to relocating
his home to the Boca Raton, Florida area. Reimbursements under this section shall be paid within sixty (60) days following date
of submission and in a manner consistent with the Company’s policies and procedures in effect from time to time for executives
of the Company at the Chief level and above.


3.      
     Term of Employment.


(a)           Termination Under Certain Circumstances.


(i)      
Death. Executive’s
employment and the Term shall be automatically terminated, without notice, effective upon the date of Executive’s death.


(ii)      Disability.
If, as a result of incapacity due to physical or mental illness or injury, Executive shall have been absent from Executive’s
full-time duties hereunder for six (6) consecutive months, then thirty (30) days after giving written notice to Executive (which
notice may occur before or after the end of such six (6) month period, but which shall not be effective earlier than the last
day of such six (6) month period), the Company may terminate Executive’s employment and the Term, provided Executive is
unable to resume Executive’s full-time duties at the conclusion of such notice period.



    4


     


    

(iii)          Termination by the Company for Good Cause.
The Company may terminate Executive’s employment and the Term upon ten (10) days prior written notice to Executive for “Good
Cause,” which shall mean any one or more of the following: (A) Executive’s material breach of this Agreement (continuing
for thirty (30) days after receipt of written notice of need to cure, if, in the Company’s determination, such breach is
curable); (B) Executive’s negligence in the performance or intentional nonperformance (continuing for thirty (30) days after
receipt of written notice of need to cure, if, in the Company’s determination, such breach is curable) of any of Executive’s
material duties and responsibilities; (C) Executive’s willful dishonesty, fraud, or misconduct with respect to the business
or affairs of the Company; (D) Executive’s indictment for, charge of, conviction of, or guilty or nolo contendre
plea to a felony crime involving dishonesty or moral turpitude whether or not relating to the Company; (E) a confirmed positive
drug test result for an illegal drug; or (F) a material sanction is imposed on Executive by any applicable professional organization
or professional governing body including, for the avoidance of doubt, an accounting regulatory board.


(iv)          Termination by the Company Without Good Cause.
The Company may terminate Executive’s employment and the Term at any time without Good Cause. A termination by Executive
without Good Reason shall not be a breach of this Agreement by Executive.


(v)           Termination by Executive Without Good Reason.
Executive, at Executive’s option and upon written notice to the Company, may terminate Executive’s employment and
the Term without Good Reason (as defined below) at any time, effective on the date of that notice.


(vi)          Termination by Executive With Good Reason.
At any time during the Term, Executive may terminate Executive’s employment and the Term for Good Reason. For purposes of
this Agreement, “Good Reason” shall mean (A) the assignment to Executive of material duties inconsistent with
Executive’s position as the Chief Financial Officer (including status, office, titles and reporting requirements), or any
other action by the Company that results in a material diminution in such position, excluding for this purpose (i) any action
not taken in bad faith and that is remedied by the Company promptly after receipt of a Notice of Termination for Good Reason (as
defined below) thereof given by Executive and (ii) any change in status, office, titles and reporting requirements following a
Change in Control of the Company in which the Company ceases to be a standalone public reporting company, provided that the material
duties of Executive following such Change in Control are not inconsistent with those of Executive immediately prior to such Change
in Control; (B) the Company requiring Executive to be based at any office or location other than in Palm Beach County, Florida,
or within thirty-five (35) miles of such location, or such other location as mutually agreed to by the Company and Executive,
except for travel reasonably required in the performance of Executive’s responsibilities, provided, however, that this clause
3(iv)(B) will not have any force or effect until such time that and only for the period of time that Executive has permanently
relocated his home and permanently resides within thirty-five (35) miles of the Company’s Boca Raton headquarters; or (C)
any material failure by the Company to comply with any of the provisions of this Agreement, other than a failure not occurring
in bad faith and that is remedied by the Company promptly after receipt of a Notice of Termination for Good Reason given thereof
by Executive. A termination of employment by Executive for Good Reason shall be effected by Executive’s giving the Board
written notice (“Notice of Termination for Good Reason”) of the termination, setting forth in reasonable detail
the specific conduct of the Company that constitutes Good Reason and the specific provision(s) of this Agreement on which Executive
relies, within ninety (90) days of the initial existence of one of the conditions constituting Good Reason. A termination of employment
by Executive for Good Reason shall be effective on the thirty-first (31st) day following the date when the Notice of Termination
for Good Reason is given to the Company; provided that such a termination of employment shall not become effective if the Company
shall have substantially corrected the circumstance giving rise to the Notice of Termination for Good Reason within thirty (30)
days after the Company’s receipt of such Notice of Termination for Good Reason.






    5


     


    

(b)        Result
of Termination.


(i)      
Except as otherwise set forth in this Agreement, in the event of the termination of Executive’s employment and the Term
pursuant to Sections 3(a)(iii) (“Termination by the Company for Good Cause”) or 3(a)(v) (“Termination
by Executive Without Good Reason”) hereof, Executive shall receive no further compensation under this Agreement
other than the payment of Base Salary as shall have accrued and remained unpaid as of the date of termination, unreimbursed business
expenses, and accrued but unused PTO consistent with the Company’s policies and procedures therefor in effect at the time
of such termination for officers of Executive’s level.


(ii)       In the event of the termination of Executive’s employment and the Term pursuant to Sections 3(a)(iv) (“Termination
by the Company Without Good Cause”) or 3(a)(vi) (“Termination by Executive With Good Reason”)
hereof, (a) Executive shall, for a period of twelve (12) months following the effective date of such termination, continue to
receive Executive’s then current annual Base Salary, as provided in Section 2(a), (b) Executive shall receive
an amount equal to Executive’s Targeted Annual Bonus Award for the calendar year in which the termination of Executive’s
employment occurs, which amount shall be paid to Executive in a single lump sum, which is unpaid on the effective date of Executive’s
termination, and which shall be paid to Executive when paid to other similarly situated executives of the Company in accordance
with Section 2(b) hereof, (c) Executive shall receive, beginning on the first payroll date occurring on or after the thirtieth
(30th) day following the effective date of the termination of Executive’s employment under this Agreement and
for a period of twenty-four (24) months thereafter for a total of twenty-four (24) monthly payments, a monthly cash payment equal
to the one (1) month cost of COBRA continuation of the health insurance benefits for Executive and Executive’s immediate
family as applicable, as the effective date of such termination, less, the one (1) month cost for the same health insurance benefits
for Executive and Executive’s immediate family as applicable that would have been incurred by Executive immediately prior
to the effective date of such termination if Executive remained employed with the Company, (d) all unvested equity compensation
of any kind (including, without limitation, stock options, restricted stock, RSUs, performance shares or PSUs) held by Executive
in Executive’s capacity as an employee of the Company on the effective date of the termination shall vest as of the effective
date of such termination, (e) Executive shall receive payment for (1) Base Salary as shall have accrued and remained unpaid as
of the date of termination, (2) unreimbursed business expenses, (3) accrued but unused PTO consistent with the Company’s
policies and procedures therefor in effect at the time of such termination for executives of the Company at the Chief level and
above, and (4) any annual short-term incentive compensation earned pursuant to Section 2(b) hereof for the calendar year immediately
preceding the calendar year in which the termination of Executive’s employment occurs which is unpaid on the effective date
of Executive’s termination, which shall be paid to Executive when paid to other similarly situated executives of the Company
in accordance with Section 2(b) hereof (the preceding clauses (e)(1), (e)(2), (e)(3) and (e)(4) collectively, the “Accrued
Compensation”).






    6


     


    

(iii)      In the event of the termination of Executive’s employment and the Term pursuant to Sections 3(a)(i) (“Death”)
or 3(a)(ii) (“Disability”) hereof, (a) Executive shall receive an amount equal to Executive’s
Targeted Annual Bonus Award for the calendar year in which the termination of Executive’s employment occurs, multiplied
by a fraction, the numerator of which is the number of full months of such calendar year during which Executive was employed with
the Company, and the denominator of which is twelve (12), which amount shall be paid to Executive in a single lump sum on the
first payroll date occurring on or after the thirtieth (30th) day following the effective date of the termination of
Executive’s employment under this Agreement, (b) all unvested equity compensation of any kind (including, without limitation,
stock options, restricted stock, RSUs, performance shares or PSUs) held by Executive in Executive’s capacity as an employee
of the Company on the effective date of the termination shall vest as of the effective date of such termination, (c) Executive
shall receive payment for the Accrued Compensation.


(iv)      In the event of the termination of Executive’s employment and the Term pursuant to Sections 3(a)(iv) (“Termination
by the Company Without Good Cause”) or 3(a)(vi) (“Termination by Executive With Good Reason”)
hereof during the twelve (12) month period immediately following a Change in Control or otherwise in connection with such Change
in Control, then in lieu of any benefits or amounts otherwise payable under Section 3(b)(ii) hereof, (a) Executive shall,
for a period of eighteen (18) months following the effective date of such termination, continue to receive Executive’s then
current annual Base Salary, as provided in Section 2(a), (b) Executive shall receive an amount equal to one and one
half times (1.5x) Executive’s Targeted Annual Bonus Award for the calendar year in which the termination of Executive’s
employment occurs, which amount shall be paid to Executive in a single lump sum on the first payroll date occurring on or after
the thirtieth (30th) day following the effective date of the termination of Executive’s employment under this
Agreement, (c) Executive shall receive, beginning on the first payroll date occurring on or after the thirtieth (30th)
day following the effective date of the termination of Executive’s employment under this Agreement and for a period of eighteen
(18) months thereafter for a total of eighteen (18) monthly payments, a monthly cash payment equal to the one (1) month cost of
COBRA continuation of the health insurance benefits for Executive and Executive’s immediate family as applicable, as the
effective date of such termination, less, the one (1) month cost for the same health insurance benefits for Executive and Executive’s
immediate family as applicable that would have been incurred by Executive immediately prior to the effective date of such termination
if Executive remained employed with the Company, (d) all unvested equity compensation of any kind (including, without limitation,
stock options, restricted stock, RSUs, performance shares or PSUs) held by Executive in Executive’s capacity as an employee
of the Company on the effective date of the termination shall vest as of the effective date of such termination, (e) Executive
shall receive payment for the Accrued Compensation.






    7


     


    

(c)         Release. Notwithstanding
any other provision in this Agreement to the contrary, as a condition precedent to receiving any post-termination payments or
benefits identified in Sections 3(b)(ii), 3(b)(iii) and 3(b)(iv) hereof, Executive agrees to execute
(and not revoke) a full and complete release of all claims against the Company and its affiliates, in the form attached hereto
as Exhibit A (subject to such modifications as the Company reasonably may request) (the “Release”). If Executive
fails to execute and deliver to the Company the Release within twenty-one (21) days following the date of termination, or revokes
the Release, within seven (7) days following the date Executive executes and delivers the Release, or materially breaches any
term of this Agreement or any other agreement between Executive and the Company while receiving such post-termination payments
or benefits, Executive agrees that Executive shall not be entitled to receive any such post-termination payments. For purposes
of this Agreement, the Release shall be deemed to have been executed by Executive if it is signed by Executive’s legal representative
in the case of legal incompetence or on behalf of Executive’s estate in the case of Executive’s death. Payment of
any post-termination payments or benefits identified in Sections 3(b)(ii), 3(b)(iii) and 3(b)(iv) hereof
shall be delayed until the first payroll date occurring on or after the thirtieth (30th) day following the effective
date of the termination of Executive’s employment under this Agreement, and any payments that are so delayed shall be paid
on the first payroll date occurring on or after the thirtieth (30th) day following the effective date of the termination
of Executive’s employment under this Agreement.


(d)         Section 409A.
Any payments made by the Company pursuant to Sections 3(b)(ii), 3(b)(iii) and 3(b)(iv) hereof (except
for unpaid annual short-term incentive compensation earned in the calendar year immediately preceding the calendar year in which
the termination of Executive’s employment occurs, which shall be paid to Executive when paid to other similarly situated
executives of the Company) shall be paid or commence on the first payroll date occurring on or after the thirtieth (30th)
day following the effective date of Executive’s “separation from service” within the meaning of Section 409A
(“Section 409A”) of the Internal Revenue Code of 1986, as amended (the “Code”). For purposes
of applying the provisions of Section 409A to this Agreement, each separately identified amount to which Executive is entitled
under this Agreement shall be treated as a separate payment. In addition, to the extent permissible under Section 409A, any series
of installment payments under this Agreement shall be treated as a right to a series of separate payments. Executive shall receive
no additional compensation following any termination except as provided herein. In the event of any termination, Executive shall
resign all positions with the Company and its subsidiaries. If Executive is a “specified employee” within the meaning
of Section 409A, then payments identified in Section 3(b) of this Agreement shall not commence until six (6) months following
“separation from service” within the meaning of Section 409A to the extent necessary to avoid the imposition of the
additional twenty percent (20%) tax under Section 409A (and in the case of installment payments, the first payment shall include
all installment payments required by this subsection that otherwise would have been made during such six-month period). If the
payments described in Section 3(b) are “deferred compensation” within the meaning of Section 409A and
must be delayed for six (6) months pursuant to the preceding sentence, Executive shall not be entitled to additional compensation
to compensate for such delay period. Upon the date such payment would otherwise commence, the Company shall reimburse Executive
for such payments, to the extent that such payments otherwise would have been paid by the Company had such payments commenced
upon Executive’s “separation from service” within the meaning of Section 409A. Any remaining payments shall
be provided by the Company in accordance with the schedule and procedures specified herein. This Agreement is intended to satisfy
the requirements of Section 409A with respect to amounts subject thereto, and shall be interpreted and construed consistent with
such intent. Any reimbursements by the Company to Executive of any eligible expenses under this Agreement that are not excludable
from Executive’s income for Federal income tax purposes (the “Taxable Reimbursements”) shall be made
by no later than the last day of the taxable year of Executive following the year in which the expense was incurred. The amount
of any Taxable Reimbursements, and the value of any in-kind benefits to be provided to Executive, during any taxable year of Executive
shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year of Executive.
The right to Taxable Reimbursement, or in-kind benefits, shall not be subject to liquidation or exchange for another benefit.
Notwithstanding the foregoing, the Company does not make any representation to Executive that the payments or benefits provided
under this Agreement are exempt from, or satisfy, the requirements of Section 409A, and the Company shall have no liability or
other obligation to indemnify or hold harmless Executive or any beneficiary for any tax, additional tax, interest or penalties
that Executive or any beneficiary may incur in the event that any provision of this Agreement, or any amendment or modification
thereof, or any other action taken with respect thereto, is deemed to violate any of the requirements of Section 409A.



    8


     


    

(e)       Section
280G. 


(i)      
Certain Reductions in Agreement Payments.
Anything in this Agreement to the contrary notwithstanding, in the event a nationally recognized independent accounting firm designated
by the Company and reasonably acceptable to Executive (the “Accounting Firm”) shall determine that receipt
of all payments or distributions by the Company and its affiliates in the nature of compensation to or for Executive’s benefit,
whether paid or payable pursuant to this Agreement or otherwise (a “Payment”), would subject Executive to the
excise tax under Section 4999 of the Code, the Accounting Firm shall determine as required below in this Section 3(e) whether
to reduce any of the Payments paid or payable pursuant to this Agreement (the “Agreement Payments”) to the
Reduced Amount (as defined below). The Agreement Payments shall be reduced to the Reduced Amount only if the Accounting Firm determines
that Executive would have a greater Net After-Tax Receipt (as defined below) of aggregate Payments if Executive’s Agreement
Payments were so reduced. If the Accounting Firm determines that Executive would not have a greater Net After-Tax Receipt of aggregate
Payments if Executive’s Agreement Payments were so reduced, then Executive shall receive all Agreement Payments to which
Executive is entitled. 


(ii)       Accounting
Firm Determinations. If the Accounting Firm determines that aggregate Agreement Payments should be reduced to the Reduced
Amount, then the Company shall promptly give Executive notice to that effect and a copy of the detailed calculation thereof. All
determinations made by the Accounting Firm under this Section 3(e) shall be binding upon the Company and Executive and
shall be made as soon as reasonably practicable and in no event later than twenty (20) days following the effective date of the
termination of Executive’s employment with the Company. For purposes of reducing the Agreement Payments to the Reduced Amount,
only amounts payable under this Agreement (and no other Payments) shall be reduced. The reduction of the amounts payable hereunder,
if applicable, shall be made (A) only from Payments that the Accounting Firm determines reasonably may be characterized as “parachute
payments” under Section 280G of the Code; (B) only from Payments that are required to be made in cash, (C) only with respect
to any amounts that are not payable pursuant to a “nonqualified deferred compensation plan” subject to Section 409A
of the Code, until those payments have been reduced to zero, and (D) in reverse chronological order, to the extent that any Payments
subject to reduction are made over time (e.g., in installments). In no event, however, shall any Payments be reduced if and to
the extent such reduction would cause a violation of Section 409A of the Code or other applicable law. All fees and expenses of
the Accounting Firm shall be borne solely by the Company.



    9


     


    

(iii)       Overpayments; Underpayments. As a result of the uncertainty in the application of Section 4999 of the Code at the time
of the initial determination by the Accounting Firm hereunder, it is possible that amounts will have been paid or distributed
by the Company to or for the benefit of Executive pursuant to this Agreement which should not have been so paid or distributed
(an “Overpayment”) or that additional amounts which will have not been paid or distributed by the Company to
or for the benefit of Executive pursuant to this Agreement which should have been so paid or distributed (an “Underpayment”),
in each case consistent with the calculation of the Reduced Amount hereunder. In the event that the Accounting Firm, based upon
the assertion of a deficiency by the Internal Revenue Service against either the Company or Executive which the Accounting Firm
believes has a high probability of success determines that an Overpayment has been made, Executive shall pay any such Overpayment
to the Company together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code; provided,
however, that no amount shall be payable by Executive to the Company if and to the extent such payment would not either
reduce the amount on which Executive is subject to tax under Section 1 and Section 4999 of the Code or generate a refund
of such taxes. In the event that the Accounting Firm, based upon controlling precedent or other substantial authority, determines
that an Underpayment has occurred, any such Underpayment shall be paid promptly (and in no event later than 60 days following
the date on which the Underpayment is determined) by the Company to or for the benefit of Executive together with interest at
the applicable federal rate provided for in Section 7872(f)(2) of the Code.


(iv)       Definitions. The following terms shall have the following meanings for purposes of this Section 3:


(A)         “Net After-Tax Receipt” shall mean the present value (as determined in accordance with Sections 280G(b)(2)(A)(ii)
and 280G(d)(4) of the Code) of a Payment net of all taxes imposed on Executive with respect thereto under Sections 1 and 4999
of the Code and under applicable state and local laws, determined by applying the highest marginal rate under Section 1 of the
Code and under state and local laws which applied to Executive’s taxable income for the immediately preceding taxable year,
or such other rate(s) as the Accounting Firm determined to be likely to apply to Executive in the relevant taxable year(s).


(B)          “Reduced
Amount” shall mean the greatest amount of Agreement Payments that can be paid that would not result in the imposition
of the excise tax under Section 4999 of the Code if the Accounting Firm determines to reduce Agreement Payments pursuant to Section
3(e)(i) hereof.



    10


     


    

4.           Competition
and Non-Solicitation.


(a)         Interests
to be Protected. The parties acknowledge that Executive will perform essential services for the Company, its employees, and
its stockholders during the term of Executive’s employment with the Company. Executive will be exposed to, have access to,
and work with, a considerable amount of confidential information. The parties also expressly recognize and acknowledge that the
personnel of the Company have been trained by, and are valuable to, the Company and that the Company will incur substantial recruiting
and training expenses if the Company must hire new personnel or retrain existing personnel to fill vacancies. The parties expressly
recognize that it could seriously impair the goodwill and diminish the value of the Company’s business should Executive
compete with the Company in any manner whatsoever. The parties acknowledge that this covenant has an extended duration; however,
they agree that this covenant is reasonable and it is necessary for the protection of the Company, its stockholders, and employees.
For these and other reasons, and the fact that there are many other employment opportunities available to Executive if Executive’s
employment is terminated, the parties are in full and complete agreement that the following restrictive covenants are fair and
reasonable and are entered into freely, voluntarily, and knowingly. Furthermore, each party was given the opportunity to consult
with independent legal counsel before entering into this Agreement.


(b)         Non-Competition.
During the term of Executive’s employment with the Company and for eighteen (18) months after the termination of Executive’s
employment with the Company, which may be extended an additional twelve (12) months in the sole and absolute discretion of the
Company for a total of thirty (30) months after termination of Executive’s employment with the Company, regardless of the
reason therefor, Executive shall not (whether directly or indirectly, as owner, principal, agent, stockholder, director, officer,
manager, employee, partner, participant, or in any other capacity) engage or become substantially and directly financially interested
in any Competitive Business Activities conducted within the Restricted Territory (as defined below). In the event of the termination
of Executive’s employment and the Term pursuant to Sections 3(a)(iv) (“Termination by the Company Without
Good Cause”) or 3(a)(vi) (“Termination by Executive With Good Reason”) hereof, if the
Company exercises its right to extend this non-competition clause by the additional twelve (12) months, then Executive will, (a)
for a period of twelve (12) additional months, continue to receive Executive’s then current annual Base Salary, as provided
in Section 2(a) hereof, and (b) Executive will receive for a period of an additional six (6), a monthly cash payment
equal to the one (1) month cost of COBRA continuation of the health insurance benefits for Executive and Executive’s immediate
family as applicable. As used herein, the term “Competitive Business Activities” shall mean business activities
that are competitive with the business of the Company, including but not limited to, business activities in the pharmaceutical
industry related to products that compete with the Company’s products, and the term “Restricted Territory”
shall mean any state or other geographical area in which the Company has demonstrated an intent to develop, commercialize, and/or
distribute products during Executive’s employment with the Company. Executive hereby agrees that, as of the date hereof,
during Executive’s employment with the Company, the Company has demonstrated an intent to develop, commercialize, and/or
distribute products throughout the United States of America, Canada, Mexico, Brazil, Argentina, Europe, Australia, South Africa,
Russia, Israel, Japan, and South Korea.



    11


     


    

(c)          Non-Solicitation
of Employees. During the term of Executive’s employment and for a period of twenty-four (24) months after the termination
of Executive’s employment with the Company, regardless of the reason therefor, Executive shall not directly or indirectly,
for the Company, or on behalf of or in conjunction with any other person, company, partnership, corporation, or governmental or
other entity, solicit for employment, seek to hire, or hire any person who is employed by the Company, is a consultant of the
Company, or is an independent contractor of the Company, within twenty-four (24) months of the termination of Executive’s
employment, and, as related solely to consultants, for the purpose of having any such consultant engage in services that are the
same as, similar to, or related to the services that such consultant provided for the Company and that are competitive with the
services provided by the consultant for the Company.


(d)          Non-Solicitation
of Customers. During the term of Executive’s employment and for a period of twenty-four (24) months after the termination
of Executive’s employment with the Company, regardless of the reason therefor, Executive shall not directly or indirectly,
for the Company, or on behalf of, or in conjunction with, any other person, company, partnership, corporation, or governmental
entity, call on, solicit, or engage in business with, any of the actual or targeted prospective customers or clients of the Company
on behalf of any person or entity in connection with any Competitive Business, nor shall Executive make known the names and addresses
of such actual or targeted prospective customers or clients, or any information relating in any manner to the trade or business
relationships of the Company with such customers or clients, other than in connection with the performance of Executive’s
duties under this Agreement, and/or persuade or encourage or attempt to persuade or encourage any persons or entities with whom
the Company does business or has some business relationship to cease doing business or to terminate its business relationship
with the Company or to engage in any Competitive Business Activities on its own or with any competitor of the Company. As used
herein, the term “Competitive Business” shall mean business that is directly competitive with the business
of the Company, including but not limited to, business in the pharmaceutical industry related to products that directly compete
with the Company’s products.


(e)          Employee Assignment, Invention and Confidentiality
Agreement. Executive hereby affirms, acknowledges, and agrees that Executive will be subject
to the terms and conditions set forth in that certain Employee Assignment, Invention, and Confidentiality Agreement (the “EAICA”)
by and between the Company and Executive and that this Agreement does not modify or amend the EAICA. 


(f)           Equitable
Relief. In the event a violation of any of the restrictions contained in this Section 4 occurs, the Company shall
be entitled to seek from a court of competent jurisdiction preliminary and permanent injunctive relief (without being required
to post bond), reasonable attorneys’ fees, and damages and an equitable accounting of all earnings, profits, and other benefits
arising from such violation, which right shall be cumulative and in addition to any other rights or remedies to which the Company
may be entitled. In the event of a violation of any provision of Section 4(b), Section 4(c), or Section
4(d) hereof, the period for which those provisions would remain in effect shall be extended for a period of time equal to
that period beginning when such violation commenced and ending when the activities constituting such violation shall have been
finally terminated in good faith.



    12


     


    

(g)          Restrictions
Separable. If the scope of any provision of this Agreement (whether in this Section 4 or otherwise) is found by
a court of competent jurisdiction to be too broad to permit enforcement to its full extent, then such provision shall be enforced
to the maximum extent permitted by law. The parties agree that the scope of any provision of this Agreement may be modified by
a judge in any proceeding to enforce this Agreement, so that such provision can be enforced to the maximum extent permitted by
law. Each and every restriction set forth in this Section 4 is independent and severable from the others, and no such
restriction shall be rendered unenforceable by virtue of the fact that, for any reason, any other or others of them may be unenforceable
in whole or in part.


5.         
Return of Company Property. At any time as requested by the Company, or upon the termination of Executive’s employment
with the Company for any reason, Executive shall deliver promptly to the Company all files, lists, books, records, manuals, memoranda,
drawings, and specifications; all other written or printed materials and computers, cell phones, and other equipment that are
the property of the Company (and any copies of them); and all other materials that may contain confidential information relating
to the business of the Company, which Executive may then have in Executive’s possession or control, whether prepared by
Executive or not.


6.         
Cooperation. Following the Term, Executive shall give assistance and cooperation willingly, upon reasonable advance notice
with due consideration for Executive’s other business or personal commitments, in any matter relating to Executive’s
position with the Company, or Executive’s expertise or experience as the Company may reasonably request, including Executive’s
attendance and truthful testimony where deemed appropriate by the Company, with respect to any investigation or the Company’s
defense or prosecution of any existing or future claims or litigations or other proceedings relating to matters in which Executive
was involved or potentially had knowledge by virtue of Executive’s employment with the Company. The Company agrees that
(a) it shall promptly reimburse Executive for Executive’s reasonable and documented expenses in connection with rendering
assistance and/or cooperation under this Section 6 upon Executive’s presentation of documentation for such expenses
and (b) Executive shall be reasonably compensated for his continued material services as required under this Section 6.
The parties agree to negotiate the reasonable compensation reference in 6(b) in good faith.


7.           
No Prior Agreements. Executive hereby represents and warrants to the Company that the execution of this Agreement by Executive
and Executive’s employment by the Company and the performance of Executive’s duties hereunder will not violate or
be a breach of any agreement with a former employer, client, or any other person or entity. Further, Executive agrees to indemnify
the Company for any claim, including, but not limited to, attorneys’ fees and expenses of investigation, by any such third
party that such third party may now have or may hereafter come to have against the Company based upon or arising out of any non-competition,
invention, or secrecy agreement between Executive and such third party that was in existence as of the date of this Agreement.



    13


     


    

 


8.           
Miscellaneous.


(a)           Notice.
All notices, requests, demands, and other communications required or permitted under this Agreement shall be in writing and shall
be deemed to have been duly given, made, and received (i) if personally delivered, on the date of delivery, (ii) if by e-mail
transmission, upon receipt, (iii) if mailed United States mail, registered or certified, return receipt requested, postage prepaid,
and addressed as provided below, upon receipt or refusal of delivery, or (iv) if by a courier delivery service providing overnight
or “next-day” delivery, upon receipt or refusal of delivery, in each case addressed as follows: 


	  To the Company:	TherapeuticsMD, Inc.
	 	951
Yamato Road, Suite 220


Boca
Raton, Florida 33431


Attention:
Chief Executive Officer


Phone:
(561) 961-1900


	 	 
	  With a copy, which shall not constitute notice, to:
	 	 
	 	TherapeuticsMD,
Inc.


951
Yamato Road, Suite 220


Boca
Raton, Florida 33431


Attention:
General Counsel


Phone:
(561) 961-1900









  


	  To Executive:	James C. D’Arecca




 


	  With a copy to:	Stewart Reifler, Esq.
	 	8
Brightfield Lane


Westport,
Connecticut 06880


Phone:
(203) 557-0722




	 	 







Either
party may alter the address to which communications or copies are to be sent by giving notice of such change of address in conformity
with the provisions of this Section 8 for the giving of notice.


(b)           Indulgences;
Waivers. Neither any failure nor any delay on the part of either party to exercise any right, remedy, power, or privilege
under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power,
or privilege preclude any other or further exercise of the same or of any other right, remedy, power, or privilege, nor shall
any waiver of any right, remedy, power, or privilege with respect to any occurrence be construed as a waiver of such right, remedy,
power, or privilege with respect to any other occurrence. No waiver shall be binding unless executed in writing by the party making
the waiver.


(c)           Controlling
Law. This Agreement and all questions relating to its validity, interpretation, performance and enforcement, shall be governed
by and construed in accordance with the laws of the State of Florida, notwithstanding any Florida or other conflict-of-interest
provisions to the contrary, unless superseded by federal law. Venue for any action arising out of this Agreement or the employment
relationship shall be brought only in courts of competent jurisdiction in or for Palm Beach County, Florida and each party hereby
irrevocably waives, to the fullest extent permitted by law, any objection which they may now or hereafter have to the laying of
venue in such courts and submits to the jurisdiction of such courts. THE PARTIES (BY THEIR ACCEPTANCE HEREOF) HEREBY KNOWINGLY,
IRREVOCABLY, VOLUNTARILY, AND INTENTIONALLY WAIVE ANY RIGHT EACH MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY DISPUTES BASED
UPON OR ARISING OUT OF THIS AGREEMENT.






    14


     


    

(d)           Execution
in Counterpart. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original
as against any party whose signature appears thereon, and all of which shall together constitute one and the same instrument.
This Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures
of the parties reflected hereon as the signatories.


(e)           Entire Agreement.
Except as herein contained, this Agreement contains the entire understanding between the parties hereto with respect to the subject
matter hereof and supersedes all prior and contemporaneous agreements and understandings, inducements, and conditions, express
or implied, oral or written, which shall no longer have any force or effect. The express terms hereof control and supersede any
course of performance and/or usage of the trade inconsistent with any of the terms hereof. This Agreement may not be modified
or amended other than by an agreement in writing signed by Executive and an authorized representative with actual authority to
bind Company.


(f)            Controlling Document.
If any provision of any agreement, plan, program, policy, arrangement or other written document between or relating to the Company
and Executive conflicts with any provision of this Agreement, the provision of this Agreement shall control and prevail.


(g)           Section Headings.
The section headings in this Agreement are for convenience only; they form no part of this Agreement and shall not affect its
interpretation.


(h)           Number of Days.
In computing the number of days for purposes of this Agreement, all days shall be counted, including Saturdays, Sundays, and holidays;
provided, however, that if the final day of any time period falls on a Saturday, Sunday, or holiday, then the final day shall
be deemed to be the next day that is not a Saturday, Sunday, or holiday.


(i)      
    Successors and Assigns. This
Agreement shall inure to the benefit of and be binding upon the successors and assigns of the parties hereto; provided that because
the obligations of Executive hereunder involve the performance of personal services, such obligations shall not be delegated by
Executive. For purposes of this Agreement, successors and assigns shall include, but not be limited to, any individual, corporation,
trust, partnership, or other entity that acquires a majority of the stock or assets of the Company by sale, merger, consolidation,
liquidation, or other form of transfer. The Company will require any successor (whether direct or indirect, by purchase, merger,
consolidation, or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and
agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if
no such succession had taken place.






    15


     


    

(j)            Tax Withholding. The
Company may withhold from any benefits payable under this Agreement all federal, state, city, or other taxes as may be required
pursuant to any law or governmental regulation or ruling.


(k)           Survival. The
respective rights and obligations of the parties hereunder shall survive any termination of Executive’s employment hereunder,
including without limitation, the Company’s obligations under Section 3 hereof and Executive’s obligations under Section
4 hereof, and the expiration of the Term, to the extent necessary to the intended preservation of such rights and obligations.


(l)           
Right to Consult with Counsel; No Drafting Party.
Executive acknowledges having read and considered all of the provisions of this Agreement carefully,
and having had the opportunity to consult with counsel of Executive’s own choosing, and, given this, Executive agrees that
the obligations created hereby are not unreasonable. Executive acknowledges that Executive has had an opportunity to negotiate
any and all of these provisions and no rule of construction shall be used that would interpret any provision in favor of or against
a party on the basis of who drafted the Agreement.


[Signature
Page Follows]




    16


     


    

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.


	 	THERAPEUTICSMD, INC.
	 	 
	 	/s/ Robert
    Finizio
	 	Robert Finizio
	 	Chief Executive Officer
	 	 
	 	EXECUTIVE:
	 	 
	 	/s/ James
    C. D’Arecca
	 	James C. D’Arecca




 


[Signature
Page to Employment Agreement] 







     


     


    

EXHIBIT
A

FORM OF SEPARATION AGREEMENT AND RELEASE


This
Separation Agreement (“Agreement”) is made between TherapeuticsMD, Inc. (“Company”) and ____________________
(“Employee”), intending to be legally bound, and in consideration of the mutual covenants contained herein, and other
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:


 


1.      
Separation and Severance. Employee’s final day of employment with Company was ____________________. Although the
parties agree that Company does not owe Employee any further consideration, as severance if this release is not executed by Employee,
Company agrees to pay Employee as set forth in Employee’s Employment Agreement dated __________________ (the “Employment
Agreement”), provided Employee executes this Agreement, complies with its terms and the terms of Employee’s Employment
Agreement[[, and does not revoke this Agreement during the Revocation Period as defined in Section 8 below.]]1 Employee
acknowledges that no other compensation of any kind remains outstanding, that the consideration provided herein is more than Employee
would otherwise be entitled to receive, that Employee shall not be entitled to any other payments or benefits from Company, and
that no other amounts are due or owing or shall become due or owing relating to any obligation, agreement, or otherwise.


 


2.      
Execution of Separation Agreement. Should Employee wish to accept this Agreement, it must be signed and returned to ________________________________
by ______________.


 


3.      
EAICA. Employee acknowledges and agrees that Employee’s obligations contained in the paragraphs 2, 3, 4, 6, 8, 9,
10 and 11 of the Employee Assignment, Invention, and Confidentiality Agreement (“EAICA”) that Employee signed on _____________________,
a copy of which is attached as Exhibit A, remain in full force and effect. The terms of this Agreement are in additional to and
do not supersede the surviving terms of the EAICA.


 


4.      
Confidentiality of Agreement. Employee understands and agrees that the existence of this Agreement and the terms and conditions
thereof, shall be considered confidential, and shall not be disclosed by Employee to any third party or entity except with the
prior written approval of Company, to Employee’s spouse or attorney or financial advisor, or upon the order of a court of
competent jurisdiction. Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement or any other agreement
between the Company and Employee shall prevent Employee from sharing information and communicating in good faith, without prior
notice to the Company, with any federal government agency having jurisdiction over the Company or its operations, and cooperating
in any investigation by any such federal government agency; provided that Employee receives no monies for compensatory or other
damages as a result of participating in any such communication or cooperation with the EEOC.


 





 



1
Employee will be entitled to a revocation period only if over the age of 40 at the date of termination.


 






    A-1 


     


    

 


5.      
Non-Disparagement. At all time Employee will refrain from and will not directly or indirectly engage in any conversation
that would tend to negatively impact Company or any of its subsidiaries or any of its past and current directors and senior executives.


 


6.      
Return of Company Property. Employee agrees to immediately return to Company any and all property of Company in Employee’s
possession, custody, or control. No severance shall be paid pursuant to this Agreement until all Company property is returned.


 


7.      
Confidential Information. Employee acknowledges that Employee has had access to Company confidential and proprietary information
and agrees that all such Confidential Information is and shall remain the exclusive property of Company. Employee further agrees
that Employee shall not publish, disclose, or otherwise make available to any third party any such Confidential Information, except
(i) as such disclosure or use may be or may have been required or appropriate in connection with his work as an employee of the
Company, (ii) when required to do so by a court of law, by any governmental agency having supervisory authority over the business
of the Company or by any administrative or legislative body (including a committee thereof) with apparent jurisdiction to order
him to divulge, disclose or make accessible such information, (iii) as to such Confidential Information that becomes generally
known to the public or trade without his violation of this Section 7 or (iv) to Employee’s spouse, attorney and/or his personal
tax and financial advisors as reasonably necessary or appropriate to advance Employee’s tax, financial and other personal
planning (each an “Exempt Person”), provided, however, that any disclosure or use of any Confidential Information
by an Exempt Person shall be deemed to be a breach of this Section 7 by Employee. Employee acknowledges and agrees that Employee
has continuing confidentiality obligations under the EAICA. Employee warrants that Employee has no materials containing Confidential
Information, but if Employee does, Employee shall return immediately to Company any and all materials containing any Confidential
Information in Employee’s possession, custody, or control. The terms of this Separation Agreement comprise confidential
information of the Company.


 


8.      
Release. That the undersigned, ________________, for good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, intending to be legally bound, and Employee’s past, present and future agents, representatives,
attorneys, affiliates, heirs, executors, assigns and successors, and all other persons connected therewith, and on behalf of all
successors and assigns, hereby releases and forever discharges TherapeuticsMD, Inc., vitaMedMD, LLC, BocaGreenMD, Inc., vitaCare
Prescription Services and all of their past, present and future agents, representatives, principals, attorneys, affiliates, owners,
parent corporations, subsidiaries, officers, directors, employees, assigns and successors, and all other persons, firms or corporations
connected or affiliated therewith (collectively “Releasees”), of and from any and all legal, equitable or other claims,
demands, setoffs, defenses, contracts, accounts, suits, debts, agreements, actions, causes of action, sums of money, judgments,
findings, controversies, disputes, or past, present and future duties, responsibilities, obligations, or suits at law and/or equity
of whatsoever kind, from the beginning of the world to the date hereof, in addition, without limitation, any and all actions,
causes of action, claims, counterclaims, third party claims, and any and all other federal, state, local and/or municipality statutes,
laws and/or regulations and any ordinance and/or common law pertaining to employment or otherwise and any and all other claims
which have been or which could have been asserted against any party in any forum.


 






    A-2 


     


    

 


By
signing this Agreement, Employee knowingly and voluntarily fully releases and forever discharges Releasees of and from all claims,
demands and liability of any kind arising under any statute, law or ordinance, including, without limitation, Title VII of the
Civil Rights Act of 1964, the Fair Labor Standards Act, the National Labor Relations Act, the Americans with Disabilities Act,
any state Human Rights Act, Fla. Stat. 448, or any facts or claims arising under the Age Discrimination in Employment Act (“ADEA”).
This release is intended to cover all actions, causes of action, claims and demands for damages, loss or injury arising from the
beginning of time until the date of this Agreement, whether presently known or unknown to Employee. However, Employee does not
waive Employee’s rights to claims which may arise after this Agreement becomes effective.


 


In
addition, Employee is hereby advised to consult with an attorney prior to executing this Agreement. Employee agrees that Employee
has been given a reasonable time in which to consider the Agreement and seek such consultation. Employee further warrants that
Employee has consulted with knowledgeable persons concerning the effect of this Agreement and all rights which Employee might
have under any and all state and federal laws relating to employment and employment discrimination and otherwise. Employee fully
understands these rights and that by signing this Agreement Employee forfeits all rights to sue Releasees for matters relating
to or arising out of employment, separation, or otherwise.


 


In
accordance with provisions of the ADEA, as amended, 29 U.S.C. §601-634, Employee is hereby provided a period of twenty-one
(21) days from the date Employee receives this Agreement to review the waiver of rights under the ADEA and sign this Agreement.
Furthermore, Employee has seven (7) days after the date Employee signs the Agreement (“Revocation Period”) to revoke
Employee’s consent. This Agreement shall not become effective or enforceable until the Revocation Period has expired. If
Employee does not deliver a written revocation to ___________________________ before the Revocation Period expires, this Agreement
will become effective.


 


Notwithstanding
anything in this Section 8 to the contrary, releases contained in this Agreement shall not apply to (i) any rights to receive
any payments or benefits pursuant to Sections 3(b)(ii), 3(b)(iii) or 3(b)(iv) of the Employment Agreement, (ii) any rights or
claims that may arise as a result of events occurring after the date this Agreement is executed, (iii) any indemnification rights
Employee may have as a former officer or director of the Company or its subsidiaries or affiliated companies, (iv) any claims
for benefits under any directors’ and officers’ liability policy maintained by the Company or its subsidiaries or
affiliated companies in accordance with the terms of such policy, (v) any claims for vested benefits under any Company pension
benefit plan or welfare benefit plan in which Employee and his dependents participate, and/or (vi) any rights as a holder of equity
securities of the Company.


 


9.      
Opportunity to Seek Counsel. The parties represent that they have had an opportunity to retain legal counsel to represent
them in connection with this matter, that they have been advised of the legal effect and consequences of this Agreement, that
they have entered into this Agreement knowingly, freely and voluntarily of their own volition, and that they have not been coerced,
forced, harassed, threatened or otherwise unduly pressured to enter into this Agreement.


 






    A-3 


     


    

10.     Reporting of Known Issues. As a further condition to your receipt of the benefits described in this Agreement, you hereby
represent and warrant that you have reported in writing to ___________________________ any unethical conduct or violations of
laws, regulations, Company policies and procedures by the Company, a Company employee, or a Company officer of which you are aware.


 


11.     No Admissions. This Agreement is not and shall not in any way be construed as an admission by either party of any wrongful
act or omission, or any liability due and owing, or any violation of any federal, state or local law or regulation.


 


12.     Miscellaneous. This Agreement may not be amended or modified except in writing signed by Employee and an authorized representative
with actual authority to bind Company, specifically stating that it is an amendment to this Agreement. This Agreement shall be
governed by and construed in accordance with Sections 4(g) (Restrictions Separable), 8(a) (Notice), 8(b) (Indulgences;
Waivers), 8(c) (Controlling Law), 8(d) (Execution in Counterpart), 8(f) (Section Headings), and 8(k)
(Right to Consult with Counsel; No Drafting Party) of the Employment Agreement. This Agreement and the Employment Agreement
constitute the entire Agreement between the parties hereto with respect to the subject matter hereof; provided, however, that
Employee’s continuing obligations to the Company under the terms of the EAICA are incorporated herein and shall remain in
full force and effect as set forth herein.





 


IN
WITNESS THEREOF, the parties hereto acknowledge, understand and agree to this Agreement and intend to be bound by all of the clauses
contained in this document.








	 	 	 	 	 	 
	EMPLOYEE	 	THERAPEUTICSMD, INC.
	 	 	 	 	 	 
	 	 	 	By:	 	 
	[Employee]	 	 	 	 
	 	 	 	Its:	 	 
	 	 	 	 	 	 
	Date: 	 	 	Date:	 	 
	 	 	 	 	 	 




 






    A-4